Sanders Morris Harris’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,709
| Closed | -$161K | – | 277 |
|
|
2025
Q1 | $161K | Hold |
27,709
| – | – | 0.02% | 260 |
|
|
2024
Q4 | $348K | Hold |
27,709
| – | – | 0.05% | 203 |
|
|
2024
Q3 | $512K | Hold |
27,709
| – | – | 0.08% | 153 |
|
|
2024
Q2 | $597K | Hold |
27,709
| – | – | 0.1% | 139 |
|
|
2024
Q1 | $746K | Hold |
27,709
| – | – | 0.14% | 116 |
|
|
2023
Q4 | $814K | Hold |
27,709
| – | – | 0.4% | 63 |
|
|
2023
Q3 | $542K | Hold |
27,709
| – | – | 0.11% | 143 |
|
|
2023
Q2 | $553K | Buy |
+27,709
| New | +$553K | 0.12% | 125 |
|
|
2023
Q1 | – | Sell |
-27,709
| Closed | -$542K | – | 230 |
|
|
2022
Q4 | $542K | Hold |
27,709
| – | – | 0.21% | 108 |
|
|
2022
Q3 | $430K | Hold |
27,709
| – | – | 0.11% | 157 |
|
|
2022
Q2 | $400K | Hold |
27,709
| – | – | 0.09% | 180 |
|
|
2022
Q1 | $439K | Hold |
27,709
| – | – | 0.09% | 182 |
|
|
2021
Q4 | $646K | Hold |
27,709
| – | – | 0.11% | 140 |
|
|
2021
Q3 | $824K | Hold |
27,709
| – | – | 0.15% | 107 |
|
|
2021
Q2 | $1.26M | Hold |
27,709
| – | – | 0.24% | 79 |
|
|
2021
Q1 | $1.16M | Hold |
27,709
| – | – | 0.25% | 75 |
|
|
2020
Q4 | $1.54M | Hold |
27,709
| – | – | 0.35% | 58 |
|
|
2020
Q3 | $772K | Buy |
+27,709
| New | +$772K | 0.21% | 100 |
|